In-Depth Inactivated Vaccines Market Report: Business Trends, Growth Factors, and Forecast to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#What CAGR Is Anticipated for the Inactivated Vaccines Market Through 2029?#_x000D_
In the recent past, there has been a significant expansion in the industry of prescription orthopedic drugs. The market, which was valued at $48.41 billion in 2024, is estimated to reach $51.06 billion in 2025, representing a compound annual growth rate (CAGR) of 5.5%. Various factors have contributed to this growth over the historic period, including a wider awareness of treatments for osteoporosis, a rise in the number of musculoskeletal disorders, an increase in sports-related injuries globally, the growth of the aged population, and the improved accessibility of healthcare services in developing regions._x000D_
_x000D_
The market for prescription orthopedic drugs is projected to experience robust growth in the coming years. The market is set to expand to “$63.86 billion in 2029 with a compound annual growth rate (CAGR) of 5.8%. The surge in the prediction period can be linked to the rising demand for biologics, an uptick in the elderly population, the expansion of healthcare services in emerging marketplaces, an increase in longstanding musculoskeletal disorders, and escalating investments dedicated to research and development of orthopedic drugs. Key trends to look out for during the forecast period encompass advancements in targeted biologics, the rise in the use of regenerative medicine therapies, development of personalized drug mixtures, strides in minimally invasive delivery techniques, boosted drug efficacy via gene therapy, breakthroughs in injectable formulas, and artificial intelligence advancements in drug development and clinical decision-making processes._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp_x000D_
_x000D_
#What Market Forces Are Driving The Inactivated Vaccines Sector In 2025 And Beyond?#_x000D_
The escalating occurrence of contagious diseases is forecasted to drive an expansion in the inactivated vaccine market. Contagious diseases, which are viruses, bacteria, parasites, or fungi-based illnesses that can be transmitted between individuals, produce a variety of symptoms and health issues. Tuberculosis is a prime example of such diseases. Inactivated vaccines, which use non-living pathogens to trigger an immune response, are highly effective in preventing diseases such as polio, hepatitis A, and influenza. In November 2023, the Centers for Disease Control and Prevention, a key national public health organization in the USA, published an article stating that the count of tuberculosis patients in the USA soared from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. As such, the escalating occurrence of contagious diseases is fueling expansion in the inactivated vaccine market._x000D_
_x000D_
_x000D_
The prescription orthopedic drugs market covered in this report is segmented – _x000D_
_x000D_
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types_x000D_
2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications_x000D_
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin _x000D_
2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol _x000D_
3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone _x000D_
4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine _x000D_
5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections_x000D_
_x000D_
#What Long-Term Trends Are Likely To Affect The Inactivated Vaccines Market?#_x000D_
Leading firms in the prescription orthopedic drugs market are strategically increasing the indications for their medications to expand their market penetration, improve patient results, and cater to underserved medical needs across various orthopedic conditions. For example, in January 2023, Heron Therapeutics Inc., a biotechnology firm based in the US, secured FDA approval for the extended use of ZYNRELEF (bupivacaine and meloxicam) for soft tissue and orthopedic procedures, encompassing foot and ankle surgeries. This prolonged-release treatment is designed uniquely to provide extended pain alleviation for up to 72 hours, thereby reducing or completely eliminating the necessity for opioids post-surgery. The widened indication currently includes more orthopedic and soft tissue procedures, including foot and ankle surgeries, thereby extending its clinical applicability. Its novel combination of two drugs yields both local anesthetic and anti-inflammatory benefits, positioning it as a holistic solution for managing post-surgery pain and promoting improved patient results._x000D_
_x000D_
#Which Firms Are Considered Leaders In The Inactivated Vaccines Market Space?#_x000D_
Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc _x000D_
_x000D_
_x000D_
_x000D_
#What Role Do Regional Policies And Investments Play In Inactivated Vaccines Market Expansion?#_x000D_
North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
